Exploratory Study to Evaluate the Safety and Efficacy of CD10367 in Subjects With Psoriasis
This is an exploratory, single-centre, investigator blinded, randomized, controlled, intra-individual study, involving subjects with psoriasis vulgaris.
The objective is to evaluate, in a modified Dumas-Scholtz psoriasis mini-zone test, the safety and efficacy of CD10367 solution at 1% and 3% after a 3-week treatment period of once daily application.
100 项与 CD-10367 相关的专利(医药)